U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06881264) titled 'A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes' on March 12.
Brief Summary: The aim of this trial is to confirm the efficacy of HR17031 in controlling glycaemia in Chinese subjects with type 2 diabetes mellitus inadequately controlled on oral antidiabetic agents
Study Start Date: April 29, 2024
Study Type: INTERVENTIONAL
Condition:
Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs
Intervention:
DRUG: HR17031 injection
HR17031 injection
DRUG: insulin glargine
insulin glargine
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
P...